Biotech

All Articles

' Medical intuition' led FDA experts to support Zevra's uncommon condition med

.Zevra Therapies' rare ailment medication seems to be to become on the course to confirmation this l...

Pfizer takes $230M attacked after axing fell short DMD gene therapy

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) genetics treatment failure has blown a $230 thousa...

AC Immune views 'site' possible in Alzheimer's medicine records

.After greater than twenty years of focus on neurodegenerative conditions, Swiss biotech air conditi...

GSK loses ph. 2 HPV vaccine over absence of best-in-class possible

.GSK has scrapped a stage 2 human papillomavirus (HPV) vaccine from its own pipe after choosing the ...

OS Therapies refiles $6M IPO to cash HER2 medication, preclinical ADCs

.OS Therapies will definitely note on the NYSE American sell swap today through a $6.4 thousand IPO ...

ALX's waning CD47 feedback cost sends out supply spiraling down

.ALX Oncology's period 2 stomach cancer response cost has deteriorated. After observing its own CD47...

Ionis centers eye condition from intendeds of Roche-partnered possibility after data let down

.Another of Ionis Pharmaceuticals' crucial midphase readouts has actually disappointed assumptions, ...

Biogen's CEO claimed no dangerous handle 2023. He's ready to become daring

.While Biogen's pharma peers are hunting for late-stage possessions with little risk, chief executiv...

Instil refills pipe in $2B biobucks take care of ImmunOnco

.Instil Biography has actually been a biotech seeking a pipeline after it ditched its own lead resou...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually restored rights to a very early Alzheimer's disease program to Denali Therapeut...